Blueprint Medicines Announces PDUFA Date Extension for New Drug Application of Avapritinib for the Treatment of Adults with Fourth-Line Gastrointestinal Stromal Tumor February 6, 2020
Menlo Therapeutics Announces Publication of Phase 2 Results for Serlopitant for the Treatment of Pruritus Associated with Psoriasis in the Journal of the American Academy of Dermatology February 5, 2020
PatientPing’s National Network of Next Generation ACO Providers Earns Over $150 Million in Savings for 2018 February 3, 2020
Vitalware Achieves #1 in KLAS Revenue Cycle, Chargemaster Management Category for the Second Year in a Row January 31, 2020
Tempest Therapeutics Announces FDA Clearance of Investigational New Drug Application for TPST-1495 and Welcomes New Investors January 30, 2020